Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1986 Oct;41(10):759–765. doi: 10.1136/thx.41.10.759

Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission.

J Wiggins, O A Arbab, D E Stableforth, J G Ayres
PMCID: PMC460473  PMID: 3538477

Abstract

Measurement of serum theophylline concentration is usually recommended before intravenous aminophylline is given to patients taking oral theophylline. Fifty patients with worsening airflow obstruction, all of whom were taking oral theophyllines and who had no contraindication to the use of parenteral aminophylline, were randomly allocated into two groups before treatment was given. The dose of aminophylline was calculated without (group A) and with (group B) knowledge of admission serum theophylline concentration. In group A a regimen incorporating corrections to account for factors affecting theophylline clearance was used in an attempt to represent a "knowledgeable" approach; in group B a formula incorporating the known serum theophylline concentration at the time of admission was used. All loading doses were given over 30 minutes as "mini infusions." The two groups were well matched for age, blood gas tensions, and severity of airflow obstruction. The results for four patients (one from group A and three from group B) were excluded from analysis after completion of the study. In each group the mean admission serum theophylline concentration measured (group A: 8.4 (SD 6.0)mg/l; group B: 7.2 (5.7)mg/l) and the aminophylline doses used (group A: loading bolus 172 (45.5)mg, infusion 815 (198)mg; group B: loading bolus 233(189)mg, infusion 788(214)mg) were similar. Mean serum theophylline concentrations during 24 hours' aminophylline treatment, number of patients with a serum theophylline concentration greater than 20 mg/l, symptoms of toxicity, and outcome were also similar in the two groups. Although satisfactory use of parenteral aminophylline was achieved for most patients without knowledge of serum theophylline concentration at the time of admission to hospital (with the aid of a "knowledgeable" clinical approach and constant infusion pumps), prompt measurement of serum theophylline concentration at the time of admission identified patients with either suboptimal or potentially hazardous theophylline concentrations.

Full text

PDF
759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbab O. A., Wiggins J., Ayres J. G., Stableforth D. E. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice. Br J Dis Chest. 1985 Apr;79(2):161–171. [PubMed] [Google Scholar]
  2. Chiou W. L., Gadalla M. A., Peng G. W. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion. J Pharmacokinet Biopharm. 1978 Apr;6(2):135–151. doi: 10.1007/BF01117448. [DOI] [PubMed] [Google Scholar]
  3. Cochrane G. M. Slow release theophyllines and chronic bronchitis. Br Med J (Clin Res Ed) 1984 Dec 15;289(6459):1643–1644. doi: 10.1136/bmj.289.6459.1643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gal P., Jusko W. J., Yurchak A. M., Franklin B. A. Theophylline disposition in obesity. Clin Pharmacol Ther. 1978 Apr;23(4):438–444. doi: 10.1002/cpt1978234438. [DOI] [PubMed] [Google Scholar]
  5. Hendeles L., Weinberger M., Bighley L. Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis. 1978 Jul;118(1):97–103. doi: 10.1164/arrd.1978.118.1.97. [DOI] [PubMed] [Google Scholar]
  6. Hendeles L., Weinberger M. Theophylline. A "state of the art" review. Pharmacotherapy. 1983 Jan-Feb;3(1):2–44. doi: 10.1002/j.1875-9114.1983.tb04531.x. [DOI] [PubMed] [Google Scholar]
  7. Hunt S. N., Jusko W. J., Yurchak A. M. Effect of smoking on theophylline disposition. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):546–551. doi: 10.1002/cpt1976195part1546. [DOI] [PubMed] [Google Scholar]
  8. Jacobs M. H., Senior R. M., Kessler G. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. JAMA. 1976 May 3;235(18):1983–1986. doi: 10.1001/jama.235.18.1983. [DOI] [PubMed] [Google Scholar]
  9. Jenne J. W., Wyze M. S., Rood F. S., MacDonald F. M. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther. 1972 May-Jun;13(3):349–360. doi: 10.1002/cpt1972133349. [DOI] [PubMed] [Google Scholar]
  10. Mitenko P. A., Ogilvie R. I. Rational intravenous doses of theophylline. N Engl J Med. 1973 Sep 20;289(12):600–603. doi: 10.1056/NEJM197309202891202. [DOI] [PubMed] [Google Scholar]
  11. Munro C. S., Prowse K. Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrations. Br Med J (Clin Res Ed) 1984 Aug 11;289(6441):354–355. doi: 10.1136/bmj.289.6441.354-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Powell J. R., Vozeh S., Hopewell P., Costello J., Sheiner L. B., Riegelman S. Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia. Am Rev Respir Dis. 1978 Aug;118(2):229–238. doi: 10.1164/arrd.1978.118.2.229. [DOI] [PubMed] [Google Scholar]
  13. Stewart M. F., Barclay J., Warburton R. Risk of giving intravenous aminophylline to acutely ill patients receiving maintenance treatment with theophylline. Br Med J (Clin Res Ed) 1984 Feb 11;288(6415):450–450. doi: 10.1136/bmj.288.6415.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Vozeh S., Kewitz G., Wenk M., Follath F. Rapid prediction of steady-state serum theophylline concentration in patients treated with intravenous aminophylline. Eur J Clin Pharmacol. 1980 Nov;18(6):473–477. doi: 10.1007/BF00874658. [DOI] [PubMed] [Google Scholar]
  15. Weinberger M. W., Matthay R. A., Ginchansky E. J., Chidsey C. A., Petty T. L. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance. JAMA. 1976 May 10;235(19):2110–2113. doi: 10.1001/jama.235.19.2110. [DOI] [PubMed] [Google Scholar]
  16. Woodcock A. A., Johnson M. A., Geddes D. M. Theophylline prescribing, serum concentrations, and toxicity. Lancet. 1983 Sep 10;2(8350):610–613. doi: 10.1016/s0140-6736(83)90691-8. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES